The Business Research Company’s Cell and Gene Therapy Manufacturing Services Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /EINPresswire.com/ — The cell and gene therapy manufacturing services sector has witnessed remarkable growth, driven by advancements in medical research and increasing demand for novel therapies. As the industry evolves, expanding clinical pipelines and technological innovations are shaping its rapid development. Below is an overview of the market size, key growth drivers, regional dynamics, and major trends defining this expanding field.
Current and Projected Market Size of the Cell and Gene Therapy Manufacturing Services Market
The market for cell and gene therapy manufacturing services has experienced significant expansion in recent years. It is projected to increase from $9.44 billion in 2025 to $11.08 billion in 2026, representing a compound annual growth rate (CAGR) of 17.4%. This growth during the historical period is largely due to a rising number of cell and gene therapy candidates entering clinical trials, early adoption of outsourced manufacturing, broader academic translational research efforts, limited manufacturing capacity within organizations, and a growing need for specialized bioprocessing services.
Looking ahead, the market is expected to continue this rapid pace, reaching $21.05 billion by 2030 with a sustained CAGR of 17.4%. Factors contributing to this forecasted surge include the increasing commercialization of cell and gene therapies, greater demand for large-scale manufacturing capabilities, expansion of personalized medicine pipelines, clearer regulatory frameworks for advanced therapies, and substantial investments in advanced therapy production infrastructure. Emerging trends likely to influence the market include the expansion of GMP-compliant manufacturing facilities, adoption of automated cell processing technologies, rising demand for scalable viral vector production, integration of advanced quality control measures, and a heightened focus on manufacturing standardization.
Download a free sample of the cell & gene therapy manufacturing services market report:
https://thebusinessresearchcompany.com/sample_request?id=98808837&type=smp&name=Cell%20%26%20Gene%20Therapy%20Manufacturing%20Services%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Understanding Cell and Gene Therapy Manufacturing Services
These services encompass the manufacturing and quality control processes essential for producing gene and cell therapy products. They support the development and production of treatments targeting degenerative diseases, tissue injuries, and genetic disorders. Key offerings in this sector include good manufacturing practice (GMP) compliant ancillary reagents, flow cytometry, immunoassays, and gene engineering services, all of which are crucial for ensuring product efficacy and safety.
High Disease Burden as a Growth Catalyst in Cell and Gene Therapy Manufacturing
One of the main drivers of growth in this market is the high prevalence of cancer and other diseases targeted by cell and gene therapies. Cancer, characterized by uncontrolled cell growth, remains a critical health challenge worldwide. The rise in cancer cases has prompted increased research and development of cell and gene therapies as promising alternatives for effective treatment.
For instance, the American Cancer Society reported that in 2025, the United States is expected to see approximately 316,950 new invasive breast cancer cases in women and 2,800 cases in men. This substantial disease burden fuels demand for innovative therapies, thereby supporting growth in the cell and gene therapy manufacturing services market.
View the full cell & gene therapy manufacturing services market report:
https://thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Fastest Growing Regions in Cell and Gene Therapy Manufacturing Services
In 2025, North America held the largest share of the cell and gene therapy manufacturing services market. However, the Asia-Pacific region is anticipated to be the fastest-growing market during the forecast period. The market report includes comprehensive coverage of key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on growth opportunities and trends.
Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
